These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8004848)

  • 1. Nephrocalcinosis in X-linked hypophosphataemic rickets: its relationship to treatment, kidney function, and growth.
    Kooh SW; Binet A; Daneman A
    Clin Invest Med; 1994 Apr; 17(2):123-30. PubMed ID: 8004848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of therapy in X-linked hypophosphatemic rickets.
    Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
    N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrocalcinosis in X-linked hypophosphataemic rickets: just how serious is the problem?
    Cole DE
    Clin Invest Med; 1994 Apr; 17(2):131-2. PubMed ID: 8004849
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutics of X-linked hypophosphatemic rickets.
    Latta K; Hisano S; Chan JC
    Pediatr Nephrol; 1993 Dec; 7(6):744-8. PubMed ID: 8130097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis.
    Reusz GS; Hoyer PF; Lucas M; Krohn HP; Ehrich JH; Brodehl J
    Arch Dis Child; 1990 Oct; 65(10):1125-8. PubMed ID: 2248503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets.
    Alon US; Levy-Olomucki R; Moore WV; Stubbs J; Liu S; Quarles LD
    Clin J Am Soc Nephrol; 2008 May; 3(3):658-64. PubMed ID: 18256372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrocalcinosis is associated with renal tubular acidosis in children with X-linked hypophosphatemia.
    Seikaly M; Browne R; Baum M
    Pediatrics; 1996 Jan; 97(1):91-3. PubMed ID: 8545232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrocalcinosis in children and adolescents: sonographic evaluation during long-term treatment with 1,25-dihydroxycholecalciferol.
    Weber G; Cazzuffi MA; Frisone F; de Angelis M; Pasolini D; Tomaselli V; Chiumello G
    Child Nephrol Urol; 1988-1989; 9(5):273-6. PubMed ID: 2856045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis in phosphate-treated hypophosphataemic rickets.
    Reusz GS; Latta K; Hoyer PF; Byrd DJ; Ehrich JH; Brodehl J
    Lancet; 1990 May; 335(8700):1240-3. PubMed ID: 1971321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.
    Patel L; Clayton PE; Brain C; Pelekouda E; Addison GM; Price DA; Mughal MZ
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):687-96. PubMed ID: 8759181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and histologic investigation of the nature of nephrocalcinosis in children with hypophosphatemic rickets and in the Hyp mouse.
    Alon U; Donaldson DL; Hellerstein S; Warady BA; Harris DJ
    J Pediatr; 1992 Jun; 120(6):899-905. PubMed ID: 1317418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.
    Carpenter TO; Mitnick MA; Ellison A; Smith C; Insogna KL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1378-83. PubMed ID: 8200940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guide-lines to the treatment of patients with X-linked hypophosphatemic rickets.
    Reusz GS
    Acta Biomed Ateneo Parmense; 1995; 66(3-4):147-51. PubMed ID: 8578931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary hypophosphatemic rickets with hypercalciuria: case report.
    Areses-Trapote R; López-García JA; Ubetagoyena-Arrieta M; Eizaguirre A; Sáez-Villaverde R
    Nefrologia; 2012 Jul; 32(4):529-34. PubMed ID: 22806288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth in children with X-linked hypophosphataemic rickets.
    Verge CF; Cowell CT; Howard NJ; Donaghue KC; Silink M
    Acta Paediatr Suppl; 1993 Mar; 388():70-5; discussion 76. PubMed ID: 8329834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
    Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrocalcinosis in X-linked hypophosphatemia: effect of treatment versus disease.
    Taylor A; Sherman NH; Norman ME
    Pediatr Nephrol; 1995 Apr; 9(2):173-5. PubMed ID: 7794712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitriol treatment in vitamin D-dependent and vitamin D-resistant rickets.
    Glorieux FH
    Metabolism; 1990 Apr; 39(4 Suppl 1):10-2. PubMed ID: 2157942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII).
    al-Aqeel A; Ozand P; Sobki S; Sewairi W; Marx S
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):229-37. PubMed ID: 8396512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors affecting the development of nephrocalcinosis, the most common complication of hypophosphatemic rickets.
    Keskin M; Savaş-Erdeve Ş; Sağsak E; Çetinkaya S; Aycan Z
    J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1333-7. PubMed ID: 26203600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.